WASHINGTON, Oct 20 (Reuters) - Two video news releases for King Pharmaceuticals’ (KG.N) pain drug Embeda left out a warning about the risk of a fatal overdose, U.S. regulators said in a letter released on Tuesday.
WASHINGTON, Oct 20 (Reuters) - Two video news releases for King Pharmaceuticals’ (KG.N) pain drug Embeda left out a warning about the risk of a fatal overdose, U.S. regulators said in a letter released on Tuesday.
